Skip to content

Polymorphisms in Inflammatory Cytokines Genes in Subjects With Obstructive Sleep Apnea

A Cross Sectional Study of Patients With Obstructive Sleep Apnea for Polymorphisms in Genes of Inflammatory Cytokines.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00395590
Enrollment
100
Registered
2006-11-03
Start date
2006-11-30
Completion date
2007-11-30
Last updated
2006-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea

Keywords

OSA inflammatory cytokines, metabolic syndrome

Brief summary

Obstructive sleep apnea is a common sleep disorder. It is known to be related with increased body mass, abdominal obesity, insulin resistance and hypertension. It is currently believed to be a feature of the metabolic syndrome. Other features of the metabolic syndrome-such as insulin resistace were found related to inflammation and inflammatory cytokines. Several polymorphisms in the genes that encode interleukin 6,inteleukin 10 and TNF-alpha have significant influence on the amounts of cytokine production. we thus hypothesize that polymorphisms related to increased pruduction are more common in subjects with OSA than in matched controls

Detailed description

Patients attending a sleep apnea clinic for evluation will be recruited. Patients found positive for OSA will be compared to the patients with a negative study for OSA for the prevalence of polymorphisms in genes of inflammatory cytokines and cytokine levels

Interventions

None listed

Sponsors

Shaare Zedek Medical Center
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients attending the sleep apnea clinic for evaluation

Exclusion criteria

* patients known to have inflammatory conditions

Contacts

Primary Contactmichal mates, MD
rheum@szmc.org.il02-6555111
Backup ContactGheona Altarescu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026